Sectoral Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Sectoral Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$685K	Sell	2,570 -230	-8%	-$53.7K	0.48%	52
2026 Q1	$728K	Sell	2,800 -454	-14%	-$102K	0.6%	43
2025 Q4	$694K	Sell	3,254 -347	-10%	-$71.7K	0.56%	46
2025 Q3	$716K	Buy	3,601 +130	+4%	+$24.2K	0.44%	60
2025 Q2	$599K	Buy	3,471 +1,380	+66%	+$225K	0.4%	63
2025 Q1	$326K	Buy	2,091 +491	+31%	+$70.1K	0.25%	60
2024 Q4	$220K	Sell	1,600 -541	-25%	-$71.1K	0.15%	72
2024 Q3	$320K	Sell	2,141 -525	-20%	-$70.9K	0.19%	74
2024 Q2	$364K	Sell	2,666 -1,345	-34%	-$183K	0.15%	75
2024 Q1	$606K	Sell	4,011 -430	-10%	-$61.4K	0.24%	61
2023 Q4	$559K	Buy	4,441 +200	+5%	+$19.9K	0.24%	73
2023 Q3	$397K	Buy	4,241 +1,445	+52%	+$135K	0.08%	110
2023 Q2	$250K	Buy	2,796 +1,106	+65%	+$96.3K	0.04%	117
2023 Q1	$181K	Hold	1,690	–	–	0.03%	113
2022 Q4	$206K	Sell	1,690 -200	-11%	-$23.2K	0.04%	112
2022 Q3	$195K	Hold	1,890	–	–	0.04%	103
2022 Q2	$176K	Sell	1,890 -4,239	-69%	-$400K	0.04%	105
2022 Q1	$719K	Hold	6,129	–	–	0.13%	91
2021 Q4	$825K	Sell	6,129 -32,521	-84%	-$4.84M	0.12%	94
2021 Q3	$6.16M	Buy	38,650 +35,100	+989%	+$4.8M	0.51%	80
2021 Q2	$467K	Buy	3,550 +300	+9%	+$40K	0.04%	116
2021 Q1	$419K	Buy	+3,250	New	+$494K	0.03%	105
2016 Q2	–	Sell	-31,100	Closed	-$577K	–	67
2016 Q1	$577K	Hold	31,100	–	–	0.03%	78
2015 Q4	$570K	Hold	31,100	–	–	0.02%	74
2015 Q3	$550K	Sell	31,100 -204,460	-87%	-$3.98M	0.03%	74
2015 Q2	$4.17M	Sell	235,560 -496,100	-68%	-$8.68M	0.17%	55
2015 Q1	$12.7M	Buy	+731,660	New	+$13.3M	0.48%	47

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sectoral Asset Management's ASND Position: Q2 2026 in Review

Sectoral Asset Management reduced its Ascendis Pharma A/S (ASND) stake by 8.2% in Q2 2026, selling an estimated $53.7K and leaving 2,570 shares worth $685K. The position accounts for 0.48% of the portfolio, ranked #52.

Sectoral Asset Management first reported a position in ASND in Q1 2015 and has held it in 27 quarters since. The position peaked at $12.7M in Q1 2015. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Sectoral Asset Management held 2,570 shares of Ascendis Pharma A/S worth $685K as of Q2 2026.
Sectoral Asset Management sold 230 Ascendis Pharma A/S shares in Q2 2026, an estimated $53.7K.
Ascendis Pharma A/S made up 0.48% of Sectoral Asset Management's portfolio in Q2 2026, its #52 holding.
Sectoral Asset Management first reported a position in Ascendis Pharma A/S in Q1 2015 and has held it in 27 quarters since.
Sectoral Asset Management's Ascendis Pharma A/S position peaked at $12.7M in Q1 2015.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.